No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Investing

Jeremy Hunt Unveils £360m Manufacturing R&D Package to Boost UK Growth

by
March 4, 2024
in Investing
0
Jeremy Hunt Unveils £360m Manufacturing R&D Package to Boost UK Growth
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

As budget week commences, the British government has introduced a new investment package aimed at propelling the UK to become a global leader in manufacturing.

Valued at £360 million, jointly funded by the government and industry, this initiative aims to support research and development (R&D) as well as manufacturing projects in sectors where the UK holds or has the potential to achieve global leadership. The funding will leverage investment from the private sector to drive innovation and competitiveness.

Key components of the package include nearly £200 million allocated for aerospace R&D projects focused on developing energy-efficient and zero-carbon aircraft technology essential for achieving net-zero aviation goals.

Additionally, £73 million of joint funding will support cutting-edge automotive R&D projects aimed at enhancing electric vehicle technology to improve efficiency and competitiveness.

The Treasury elaborated that supported by over £36 million in government funding through Advanced Propulsion Centre UK competitions, this initiative encompasses four projects aimed at advancing technologies for the next generation of battery electric vehicles. These efforts, led by companies including automotive manufacturers YASA and Empel Systems, aim to enhance efficiency and competitiveness in the electric vehicle sector.

Furthermore, the government will contribute £7.5 million to facilitate the expansion of two pharmaceutical companies’ UK plants. Almac, based in Northern Ireland, focuses on producing drugs to treat diseases such as cancer, heart disease, and depression, while Ortho Clinical Diagnostics, located in Pencoed, Wales, specializes in manufacturing medical testing products.

Chancellor of the Exchequer, Jeremy Hunt, emphasized that this investment will safeguard jobs and foster economic growth, asserting, “We’re committed to supporting the industries of the future by injecting millions of pounds into investment to establish the UK as a global leader in manufacturing. This initiative will secure highly skilled jobs and drive long-term transformation, ensuring a brighter future for Britain.”

The UK’s economy necessitates increased investment, as highlighted by the IPPR think tank’s assessment that the country ranks lowest among G7 nations in terms of business investment, perpetuating a growth “doom loop.”

Despite this investment, Labour’s shadow business secretary, Jonathan Reynolds, remains critical, asserting that the government fails to provide the long-term stability essential for manufacturing prosperity. Reynolds emphasized that recycled announcements are insufficient to reverse the UK’s stagnant business investment, which remains the lowest among G7 nations.

This funding announcement coincides with Hunt’s finalization of Wednesday’s budget, with pressure from Tory MPs to introduce tax cuts aimed at pleasing voters. However, amidst concerns about the state of UK public services, including funding for the NHS and other vital services, the appeal of income tax reductions may be eclipsed. An opinion poll conducted by the Joseph Rowntree Foundation underscores widespread apprehension about NHS and public services funding, indicating greater priority placed on these issues compared to concerns about tax on earnings.

Read more:
Jeremy Hunt Unveils £360m Manufacturing R&D Package to Boost UK Growth

Previous Post

Elon’s Boring Line of Bull

Next Post

Private REITs Hide Commercial Real Estate Distress While Begging for Bailouts

Next Post

Private REITs Hide Commercial Real Estate Distress While Begging for Bailouts

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024

Last Day to Give in 2023!

December 31, 2023
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

The Producer Price Index

September 9, 2023

China’s Strengths Are Over-Exaggerated

0

0

0

0

China’s Strengths Are Over-Exaggerated

June 7, 2025

Paul Heyne: The Ethicist Who Thought Like an Economist

June 7, 2025

Preparing for War

June 7, 2025
I Shot the Tariff (But I Swear It Was in Self-Defense)

I Shot the Tariff (But I Swear It Was in Self-Defense)

June 6, 2025

Recent News

China’s Strengths Are Over-Exaggerated

June 7, 2025

Paul Heyne: The Ethicist Who Thought Like an Economist

June 7, 2025

Preparing for War

June 7, 2025
I Shot the Tariff (But I Swear It Was in Self-Defense)

I Shot the Tariff (But I Swear It Was in Self-Defense)

June 6, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.